Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-140-9 | CAS number: 75214-72-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- September/October, 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- not specified
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- Cobaltate(3-), bis[4-[4-[[4-[4-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, trisodium
- EC Number:
- 278-140-9
- EC Name:
- Cobaltate(3-), bis[4-[4-[[4-[4-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, trisodium
- Cas Number:
- 75214-72-1
- Molecular formula:
- C52H40CoN18Na3O16S4
- IUPAC Name:
- Cobaltate(3-), bis[4-[4-[[4-[4-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, trisodium
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River U.K. Limited, Margate, Kent, England
- Females: vergin
- Age at study initiation: approximately four to six weeks
- Weight at study initiation: from 73 to 93 g
- Housing: in groups in metal cages with wire mesh floors
- Diet (e.g. ad libitum): Access to a standard laboratory rodent diet prevented approximately 18 ± 2 h prior to and 4 h after dosing; the batch of diet used for the study was analysed for certain chemical and microbiological contaminants
- Water: ad libitum
- Acclimation period: for a minimum period of four days prior to the start of the study
- Identification: each animal at each dose level was identified by cage number and ear punching.
ENVIRONMENTAL CONDITIONS
- Temperature: 22-20 °C, recorded daily on a maximum and minimum thermometer
- Humidity: not controlled but remained at a mean of 48 % RH recorded daily on a wet and dry bulb hygrometer
- Air changes: approximately 15 air changes/h
- Lighting: controlled by means of a time switch to a 12 h light/dark cycle.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: aqueous methyl cellulose (1 %)
- Details on oral exposure:
- The test substance was prepared as a 40 w/v suspension in the vehicle and dosed at a volume not exceeding 37.5 ml/kg. The test sample was prepared freshly on the day of dosing.
- Doses:
- 5 g/kg bw
- No. of animals per sex per dose:
- Main study:
- control group: 5 males and 5 females
- treatment group: 5 males and 5 females
Preliminary study:
- control group: 5 males and 5 females
- low-dose group: 5 males and 5 females
- high-dose group: 2 males and 2 females - Control animals:
- yes
- Remarks:
- A vehicle control group of five male and five female rats was treated with aqueous methyl cellulose (1 %) at the same dose volume as the test group.
- Details on study design:
- TREATMENT PROCEDURE
Administration of test sample:
A rubber catheter was used. The concentration of test substance in the vehicle was the same for all dosage levels. The dosed volume was varied to achieve the necessary dosage levels. Control animals were dosed with aqueous methyl cellulose (1 %) at 12.5 ml/kg bw.
OBSERVATION
Animals were observed soon after dosing; then at hourly-intervals for the remainder of Day 1. On subsequent days the animals were observed once in the morning and once at the end of the experimental day (this was approximately 11.30 a.m. on Saturday and Sunday). Clinical signs were recorded at each observation.
The animals on both the preliminary and main studies were observed for 14 days after dosing.
The following were recorded:
- Approximate time of death of individual rats.
- The nature, severity, approximate time of onset and duration of each toxic sign.
- Individual bodyweights on Days 1, 8 and 15.
POST MORTEN EXAMINATION
Surviving animals were killed on Day 15. All animals that died during the study and those killed on Day 15 were subjected to a macroscopic post mortem examination. The macroscopic appearance of abnormal organs was recorded.
Results and discussion
- Preliminary study:
- Control group: 0 % mortality; 5 male and 5 female animals survived
Low-dose group: 0 % mortality; 5 male and 5 female animals survived
High-dose group: 100 % mortality; 2 male and 2 female animals died
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no mortalities.
- Clinical signs:
- Signs of reaction to treatment observed shortly after dosing in treated rats at 5 g/kg included pilo-erection and abnormal body carriage (hunched posture). These signs were accompanied by abnormal gait (waddling) in three males and three females, by diarrhoea in one male and two females and by lethargy in one male and three females.
Pilo-erection only was observed in the controls.
Recovery of all treated rats, as judged, by external appearance and behaviour, was apparently complete within seven days of dosing. - Body weight:
- The bodyweight gains of male rats treated at 5 g/kg were very slightly depressed during the second week of observation compared to the controls. Bodyweight gains of female treated rats were normal throughout the two-week observation period compared to the controls.
- Gross pathology:
- Terminal autopsy findings were normal.
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified according to CLP Regulation (EC) no. 1272/2008
- Conclusions:
- The LD50 (rat, oral) of the test item was found to be greater than 5000 mg/kg bw.
- Executive summary:
The acute oral toxicity of the test item was evaluated in an experimental study according to an internal method, similar to the OECD Guideline 401. Based on the results of a preliminary study, five male and five female Sprague-Dawley rats were administered 5 g/kg bw in aqueous methyl cellulose (1 %) by oral gavage. A vehicle control group of five males and five females was treated with aqueous methyl cellulose. Clinical signs and mortality were recorded during an observation period of 14 days. Thereafter, all animals were subjected to a macroscopic examination.
No mortalities were observed in the treatment or control group. Terminal autopsy findings were normal. Clinical signs among treatment animals included pilo-erection and abnormal body carriage (hunched posture), accompanied by abnormal gait (waddling) in three males and three females, by diarrhoea in one male and two females and by lethargy in one male and three females. Pilo-erection only was observed in some control animals. All treated animals recovered within seven days of dosing. The median lethal dose (LD50) of the test item to rats is therefore greater than 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.